mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells

Walaa Eid1,2, Kristin Dauner3, Kevin C Courtney1

  • 1Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8L6.

Insights

Mammalian target of rapamycin complex 1 (mTORC1) activates SREBP-2, a cholesterol synthesis regulator, by suppressing autophagy and endosomal recycling. This mechanism lowers ER cholesterol, thereby activating SREBP-2.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of cholesterol homeostasis

Background:

  • Mammalian target of rapamycin complex 1 (mTORC1) activates sterol regulatory element-binding proteins (SREBPs), key regulators of cholesterol synthesis.
  • Activated SREBP-2 translocates to the nucleus to promote cholesterol synthesis gene expression.
  • Low endoplasmic reticulum (ER) cholesterol is a known trigger for SREBP-2 activation.

Purpose of the Study:

  • To investigate the mechanism by which mTORC1 activates SREBP-2, specifically examining its role in cholesterol delivery to the ER.
  • To determine if mTORC1 influences SREBP-2 activation by modulating cholesterol transport pathways.

Main Methods:

  • Investigated the relationship between mTORC1 activity, ER cholesterol levels, and SREBP-2 activation.
  • Utilized pharmacological inhibitors (U18666A) and genetic manipulation (NPC1 siRNA, Atg5-/-, dominant-negative rab5, Atg7 overexpression) to disrupt lysosomal cholesterol export and membrane trafficking pathways.
  • Assessed the impact of these manipulations on ER cholesterol levels and SREBP-2 activation.

Main Results:

  • mTORC1 activation correlated with decreased ER cholesterol and increased SREBP-2 activation.
  • Inhibition of cholesterol exit from lysosomes led to SREBP-2 activation independently of mTORC1.
  • Blocking autophagy and endosomal recycling to lysosomes caused SREBP-2 activation when mTORC1 activity was low.
  • Forced autophagy elevated ER cholesterol and suppressed SREBP-2 activation, even with high mTORC1 activity.

Conclusions:

  • mTORC1 suppresses autophagy and promotes endosomal recycling, preventing cholesterol-laden endosomes and autophagosomes from reaching lysosomes.
  • This suppression of lysosomal cholesterol delivery leads to reduced ER cholesterol levels.
  • The resulting low ER cholesterol activates SREBP-2, thereby promoting cholesterol synthesis.

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.7K
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K